Baycrest

SAMPLE PROJECTS LED BY RRI SCIENTISTS Real-time fall detection for older adults with dementia Falls are one of the top reasons for hospitalization among older adults. Due to issues with mobility, balance and strength, older adults with dementia are four to five times more likely to sustain a fall compared to those without a cognitive impairment. To reduce falls among these individuals, Baycrest is testing fall detection and prevention technology that employs artificial intelligence and machine learning in our long-term care home, the Apotex Centre, Jewish Home for the Aged. Through CABHI's Industry Innovation Partnership Program (I 2 P 2 ), Baycrest will be the first Canadian trial site for SafelyYou, a company created by researchers from the University of California, Berkeley. A multi- disciplinary research team comprised of RRI scientists, KL-CARE, clinical leaders, point-of-care staff, residential care leaders, IT specialists, and corporate services, is working to implement and test this unique technology with residents with dementia in the Apotex, and to develop predictive tools that will determine who will benefit most from the technology. Trials are expected to start in spring 2019. Treating the brain through wearable devices Caregivers of older adults with dementia experience higher levels of distress, and are more likely to develop dementia themselves. Mindfulness meditation training is emerging as a key tool to help with stress management, but traditional training programs are challenging to access and complete for individuals with cognitive impairment and their caregivers. Now, thanks to CABHI's I 2 P 2 , clients and caregivers at Baycrest's Sam and Ida Ross Memory Clinic soon will have the opportunity to access a personal meditation assistant, which can be used in their own homes, while also contributing to dementia research. Clinicians, RRI scientists, KL-CARE, and healthcare staff have partnered with a neurotechnology company, InteraXon, to assess whether their brain-sensing Muse™ headband can effectively bring mindfulness meditation into the homes of individuals with cognitive impairment, and whether Muse™ helps increase well-being among clients and their caregivers. By incorporating Muse™ technology into the testing regimen of the memory clinic, the research will also help determine whether changes in an individual's brain waves signal the onset of dementia before symptoms appear. 2017–2018 YEAR IN REVIEW 25

• Cover